🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study is to assess the safety, tolerability, and pharmacokinetics (PK)...
Status
Completed
Location
Multiple Locations
Start Date
2014-08
Trial ID
NCT02176876
Treatments Being Tested
This study will estimate the absolute bioavailability of subcutaneously inj...
Status
Completed
Location
Multiple Locations
Start Date
2014-08
Trial ID
NCT02209987
Treatments Being Tested
Despite surgery and first-line standard of care which consist of radiothera...
Status
Unknown
Location
Assistance Publique des Hôpitaux de Marseille
Start Date
2019-01-01
Trial ID
NCT03631836
The primary objective of the study is to determine the maximum tolerated do...
Status
Completed
Location
Alabama Oncology
Start Date
2013-03-29
Trial ID
NCT01803282
The primary objective of the study is to assess the safety and tolerability...
Status
Completed
Location
Advanced Pharma CR, LLC
Start Date
2014-03-11
Trial ID
NCT02077465
Treatments Being Tested
The primary objective of this study is to evaluate the effect of andecalixi...
Status
Terminated
Location
Multiple Locations
Start Date
2016-11-04
Trial ID
NCT02759562
Treatments Being Tested
The primary objectives of this study are as follows: 1) To evaluate the eff...
Status
Terminated
Location
Multiple Locations
Start Date
2015-09
Trial ID
NCT02520284
Treatments Being Tested
This study is researching an experimental drug called andecaliximab. The st...
Status
Active Not Recruiting
Location
University of California San Francisco (UCSF)
Start Date
2024-10-25
Trial ID
NCT06508021
Treatments Being Tested
The primary objective of this study is to compare the efficacy of andecalix...
Status
Completed
Location
Scripps Green Hospital
Start Date
2015-10-13
Trial ID
NCT02545504
Treatments Being Tested
The primary objective of this study is to characterize the safety and toler...
Status
Terminated
Location
Multiple Locations
Start Date
2016-09-20
Trial ID
NCT02862535
Treatments Being Tested